PERCEPTIVE ADVISORS LLC - 31 Dec 2024 SCHEDULE 13G/A Report for Amylyx Pharmaceuticals, Inc. Common Stock, $0.0001 par value per share (AMLX)

Filing Manager
PERCEPTIVE ADVISORS LLC
Reporting Manager
Perceptive Advisors LLC
Security
Amylyx Pharmaceuticals, Inc. Common Stock, $0.0001 par value per share
Symbol
AMLX
Shares outstanding
85,751,241 shares
Disclosed Ownership
6,774,348 shares
Ownership
7.9%
Form type
SCHEDULE 13G/A
Filing time
14 Feb 2025, 16:15:06 UTC
Date of event
31 Dec 2024
Next filing
15 May 2025
SEC
View on sec.gov

Reporting Managers (3)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Perceptive Advisors LLC 7.9% 6,774,348 0 6,774,348 /s/ Joseph Edelman Joseph Edelman, Managing Member
Joseph Edelman 7.9% 6,774,348 0 6,774,348 /s/ Joseph Edelman Joseph Edelman
Perceptive Life Sciences Master Fund, Ltd. 7.9% 6,774,348 0 6,774,348 /s/ Joseph Edelman Joseph Edelman, Managing Member